MktsMarkets

Cytek Biosciences, Inc.
NASDAQ: CTKBKey statistics
CTKB News
Stories mentioning CTKB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 44,135 | 62,141 | 52,293 | 45,602 | 41,457 | 57,476 | 51,500 | 46,617 |
| Cost of Goods Sold | 22,881 | 29,256 | 24,742 | 21,735 | 21,300 | 23,824 | 22,495 | 21,181 |
| Gross Profit | 21,254 | 32,885 | 27,551 | 23,867 | 20,157 | 33,652 | 29,005 | 25,436 |
| Operating Expenses | ||||||||
| Research & Development | 9,604 | 8,961 | 8,956 | 8,826 | 9,725 | 9,723 | 9,882 | 10,001 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 39,717 | 38,478 | 36,743 | 34,491 | 35,132 | 30,666 | 33,253 | 33,963 |
| Operating Income (Loss) | (18,463) | (5,593) | (9,192) | (10,624) | (14,975) | 2,986 | (4,248) | (8,527) |
| Interest Income | 787.00 | 580.00 | 573.00 | 555.00 | 508.00 | 913.00 | 1,433 | 1,416 |
| Interest Expense | ||||||||
| Other Expense | 565.00 | 257.00 | 1,344 | 3,708 | 3,492 | 490.00 | 3,091 | 59.00 |
| Pretax Income | (4,031) | (7,769) | (6,775) | (11,266) | 10,322 | 157.00 | (7,186) | |
| Tax Provision | 1,493 | 40,045 | (2,291) | (1,192) | 136.00 | 680.00 | (784.00) | 3,248 |
| Net Income (Loss) | (18,866) | (11,402) | ||||||
| Earnings Per Share (Basic) | 0.00 | 0.00 | ||||||
| Earnings Per Share (Diluted) | 0.00 | 0.00 | ||||||
| Weighted Average Shares Outstanding (Basic) | 128,705 | 127,746 | 127,548 | 126,934 | 128,339 | 130,611 | 131,004 | 131,440 |
| Weighted Average Shares Outstanding (Diluted) | 128,705 | 127,746 | 127,548 | 126,934 | 128,339 | 130,611 | 132,786 | 131,440 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CTKB
Cytek Biosciences, Inc. (NASDAQ: CTKB) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTKB. It last traded at $5.94 (Nov 18, 2026, 11:34 AM ET), up 4.2% on the day. That gives Cytek Biosciences a market capitalisation of $745.5M.
Over the past 52 weeks CTKB has traded between $3.31 and $6.33.
Revenue for the quarter ended Mar 31, 2026 was $44.1M; a net loss of $18.9M. Revenue was up 6.5% from $41.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $44.1M | -$18.9M | -42.7% |
| Dec 31, 2025 | $62.1M | — | — |
| Sep 30, 2025 | $52.3M | — | — |
| Jun 30, 2025 | $45.6M | — | — |
From Cytek Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…